Skip to main content
Hofseth BioCare ASA (OSL:HBC)
Norway flag Norway · Delayed Price · Currency is NOK
2.120
+0.020 (0.95%)
May 9, 2025, 4:25 PM CET

Hofseth BioCare ASA Revenue

In the year 2024, Hofseth BioCare ASA had annual revenue of 265.54M NOK with 21.52% growth. Hofseth BioCare ASA had revenue of 64.89M in the quarter ending December 31, 2024, with 36.82% growth.

Revenue
265.54M
Revenue Growth
+21.52%
P/S Ratio
3.28
Revenue / Employee
3.54M
Employees
71
Market Cap
871.49M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2024265.54M47.03M21.52%
Dec 31, 2023218.51M98.06M81.42%
Dec 31, 2022120.45M32.83M37.47%
Dec 31, 202187.62M18.36M26.52%
Dec 31, 202069.25M1.47M2.17%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Medistim ASA 603.92M
Nordhealth AS 537.23M
Photocure ASA 532.69M
Vistin Pharma ASA 440.66M
Nykode Therapeutics AS 104.04M
Omda AS 426.27M
Gentian Diagnostics ASA 158.07M
ArcticZymes Technologies ASA 102.97M
Revenue Rankings

Hofseth BioCare ASA News

More News